SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2.16 Cr | ₹-6.08 Cr | ₹7.28 Cr | ₹1.20 Cr | ₹-5.47 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SHREE GANESH REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹2.16 Cr |
| Mar2025 | ₹-6.08 Cr |
| Mar2024 | ₹7.28 Cr |
| Mar2020 | ₹1.20 Cr |
| Mar2019 | ₹-5.47 Cr |
How is Net Cash Inflow / Outflow of SHREE GANESH REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.16 Cr | Positive | |
| Mar2025 | ₹-6.08 Cr | Negative | |
| Mar2024 | ₹7.28 Cr | 505.66 | |
| Mar2020 | ₹1.20 Cr | Positive | |
| Mar2019 | ₹-5.47 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹835.4 Cr | -2.2% | -6.5% | 36.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -2.2% |
-6.5% |
36.3% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses